to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Young biotech companies sometimes face a valley of death in funding, but a venture capital researcher is challenging that idea. Read more about the early stage funding valley of death.
Convertible debt is a fundraising mechanism used in any stage of a new healthcare business, but it may be especially appealing in the early stages.
Serial entrepreneur and investor Reid Hoffman encourages individuals to become the entrepreneurs of their own lives. Hoffman shares the importance of taking intelligent risks, building thoughtful networks and continually adapting your skills to navigate a fulfilling career path.
Getting a CE Mark in Europe has allowed American medical device makers to commercialize quickly before getting U.S. Food and Drug Administration approval to sell medical devices domestically. Read about how the less stringent European regulation methods are now being questioned.
How do you impress an investor? Here are 10 tips about what to say and how to say it when making your pitch. Read more for ideas you can use in honing your pitch today.
Pfizer Inc. is testing a pilot of a virtual clinical trial program that could be of interest to medical device startups and young pharmaceutical and biotech companies.
JOYUS Founder and Chairman Sukhinder Singh Cassidy says entrepreneurs should leverage trademark strengths and lean in all the way when it's time to deliver. In this lecture, Singh Cassidy explores concepts such as defining operational range, using data to support gut beliefs, and developing the big ideas teams and customers can rally around.
StartUp Health classes will begin next month, giving entrepreneurs a structured program to launch a healthcare business. Read more about the program for startup businesses.
Early stage company entrepreneurs have been warned about a "valley of death" for funding. Read about whether it's real or just a myth.
A new Kauffman Foundation report points to what might be a long-term bridge over the most difficult funding stage for startups—the 'Valley of Death.' In that timeframe, after entrepreneurs have exhausted friends, family, and personal credit and before they're ready for external funding, some startups struggle to raise enough capital to stay alive.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.